Iceland vs Ireland: Life science patents granted, by technology
Iceland
3 patents
in 2021
Ireland
3 patents
in 2023
Iceland rank
48th
Ireland rank
48th
Life science patents granted, by technology over time
- Iceland
- Ireland
How they compare
Iceland currently reports 3 patents against 3 patents in Ireland, a difference of 0 patents.
The two have swapped places 5 times across 29 shared years of data; in 1983 it was Ireland ahead.
Iceland ranks 48th and Ireland ranks 48th of 65 countries.
Across the 5 decades both report, Iceland averaged higher in 3 and Ireland in 2.
Head to head by decade
| Decade | Iceland | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.14 patents | 169.86 patents | 166.71 patents | Ireland |
| 1990s | 5.2 patents | 244.5 patents | 239.3 patents | Ireland |
| 2000s | 21 patents | 7.25 patents | 13.75 patents | Iceland |
| 2010s | 11.33 patents | 3.5 patents | 7.83 patents | Iceland |
| 2020s | 2.5 patents | 1.5 patents | 1 patents | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Iceland or Ireland?
- Iceland, at 3 patents against 3 patents in Ireland as of 2021.
- What is the difference in life science patents granted, by technology between Iceland and Ireland?
- 0 patents, with Iceland ahead.
- How many years of comparable data are there for Iceland and Ireland?
- 29 years are reported by both, from 1983 to 2021.
- How do Iceland and Ireland rank globally for life science patents granted, by technology?
- Iceland ranks 48th and Ireland ranks 48th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.